Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
28.5M
-
Shares change
-
+28.5M
-
Total reported value, excl. options
-
$941M
-
Value change
-
+$941M
-
Number of buys
-
44
-
Price
-
$33.90
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q3 2020
44 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q3 2020.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.5M shares
of 57.1M outstanding shares and own 49.98% of the company stock.
Largest 10 shareholders include FMR LLC (9.06M shares), Vivo Capital, LLC (4.53M shares), Novo Holdings A/S (3.75M shares), venBio Partners LLC (3.5M shares), Newlight Partners LP (2.67M shares), JANUS HENDERSON GROUP PLC (875K shares), Aisling Capital Management LP (843K shares), PERCEPTIVE ADVISORS LLC (435K shares), MILLENNIUM MANAGEMENT LLC (414K shares), and BAKER BROS. ADVISORS LP (400K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.